Human Reproduction, Vol. 14, No. 3, 712-715,
March 1999
© 1999 European Society of Human Reproduction and Embryology
Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization
1 Department of Obstetrics and Gynaecology, Solihull Hospital, Solihull, West Midlands, B91 2JL and 2 Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford Radcliffe Hospital, Oxford, UK
The effect of extremes of body mass on ovulation is well recognized by clinicians. However, the effect of obesity and extreme underweight on the outcome of in-vitro fertilization (IVF) cycles has received relatively little attention. In a retrospective nested case-control study we examined the effect of the extremes of body mass index (BMI) on IVF–embryo transfer outcome at a university-based IVF unit. A total of 333 patients were included in the study; 76 obese patients (BMI > 27.9) with 152 controls, and 35 underweight patients (BMI < 19) with 70 controls. The patients were matched with their controls in age ± 1 year, day 3 follicle stimulating hormone (FSH) concentration, daily dose of gonadotrophin (±37.25 IU), gonadotrophin preparation and the year of treatment. The following parameters were compared between the study and control groups: duration of administration and dose of gonadotrophin, number of follicles aspirated, number of eggs, fertilization rate, number of embryos, serum oestradiol concentration on human chorionic gonadotrophin (HCG) day (peak oestradiol), clinical pregnancy rate, implantation rate, miscarriage rate, and incidence of ovarian hyperstimulation syndrome. Apart from a significantly lower peak oestradiol concentration (P = 0.009) in the obese patients, they and the underweight patients were not significantly different from their normal controls. The extremes of body mass index do not adversely affect the outcome of IVF–embryo transfer treatment. However, the obese patients had lower peak oestradiol concentrations than their normal controls despite receiving similar gonadotrophin doses.
Key words: body mass index/IVF–embryo transfer/obesity/underweight
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, E. Kolibianakis, W. Ledger, C. Tomas, and B. C.J.M. Fauser Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum. Reprod., April 1, 2009; 24(4): 764 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maheshwari, G. Scotland, J. Bell, A. McTavish, M. Hamilton, and S. Bhattacharya The direct health services costs of providing assisted reproduction services in overweight or obese women: a retrospective cross-sectional analysis Hum. Reprod., March 1, 2009; 24(3): 633 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Sneed, M. L. Uhler, H. E. Grotjan, J. J. Rapisarda, K. J. Lederer, and A. N. Beltsos Body mass index: impact on IVF success appears age-related Hum. Reprod., August 1, 2008; 23(8): 1835 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Minge, B. D. Bennett, R. J. Norman, and R. L. Robker Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone Reverses the Adverse Effects of Diet-Induced Obesity on Oocyte Quality Endocrinology, May 1, 2008; 149(5): 2646 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Veleva, A. Tiitinen, S. Vilska, C. Hyden-Granskog, C. Tomas, H. Martikainen, and J. S. Tapanainen High and low BMI increase the risk of miscarriage after IVF/ICSI and FET Hum. Reprod., April 1, 2008; 23(4): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maheshwari, L. Stofberg, and S. Bhattacharya Effect of overweight and obesity on assisted reproductive technology a systematic review Hum. Reprod. Update, September 1, 2007; 13(5): 433 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fedorcsak, P. O. Dale, R. Storeng, G. Ertzeid, S. Bjercke, N. Oldereid, A. K. Omland, T. Abyholm, and T. Tanbo Impact of overweight and underweight on assisted reproduction treatment Hum. Reprod., November 1, 2004; 19(11): 2523 - 2528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lashen, K. Fear, and D.W. Sturdee Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study Hum. Reprod., July 1, 2004; 19(7): 1644 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang Improving reproductive performance in overweight/obese women with effective weight management Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C.W. Chan, E. H.Y. Ng, M. M.Y. Chan, O. S. Tang, E. Y.L. Lau, W. S.B. Yeung, and P.-c. Ho Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women Hum. Reprod., November 1, 2003; 18(11): 2294 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Loh, J. X. Wang, and C. D. Matthews The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients Hum. Reprod., May 1, 2002; 17(5): 1207 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.P. Hohmann, J.S.E. Laven, F.H. de Jong, M.J.C. Eijkemans, and B.C.J.M. Fauser Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development Hum. Reprod., May 1, 2001; 16(5): 846 - 854. [Abstract] [Full Text] [PDF]
|
|